Patients Speak

Hear from patients who participated in the I-SPY 2 clinical trial as they discuss their feelings about their breast cancer diagnoses, how and why they decided to participate in the I-SPY 2 trial, their experiences on the trial, and more.

As you watch, please remember that each patient’s situation, preferences and priorities are individual to them, just as their cancers are.

Alex (2:19)

Physician/mother diagnosed at 38
Searched for a clinical trial at an academic medical center
Impact of loss of hair on her child

Vidya (2:16)

Diagnosed with Stage 3 breast cancer
Has a young child
Initially skeptical of clinical trials
How I-SPY 2 is a different type of trial
Importance of clinical trials

Marcella (1:43)

Diagnosed with Triple Negative breast cancer
Invited to join I-SPY 2 Trial by her medical oncologist
Felt uncertainty about joining a clinical trial
Wants to help women of color learn about participation in research
Enjoyed easy access to study care team

Lainey(2:35)

Diagnosed with Stage 3 breast cancer
Had infant child
‍I-SPY 2 Trial offered her hope
Why she joined the trial
Her relationship with study care team
Liked having information/choice/control over treatment decisions

Yvonne (1:23)

Diagnosed with HER2 positive breast cancer
Invited to join the I-SPY 2 Trial
Why she decided to participate
Her close relationship with study care team

Jillia (1:31)

Had lots of questions for study care team
Appreciated possibility of a lumpectomy vs. mastectomy
Appreciated possibility of shorter chemotherapy regimen
Liked optional participation throughout the trial
Liked extra attention from study care team and extra information

Barri (1:44)

Diagnosed with Triple Negative breast cancer
How she decided to join I-SPY 2 Trial
Traveled 2-3 hours to participate
Study care team treated her as an individual
Highest quality medical care

Anne Marie (1:49)

Young mother with children
Reasons for participating in I-SPY 2 Trial
I-SPY 2 Trial guided her medical care instead of adding an extra burden
Pros of joining the trial outweighed any cons

Be sure to take a look at Frequently Asked Questions about the I-SPY 2 Trial to get answers to any questions you may still have.

Or you can contact your closest trial location to get your questions answered or express your interest in participating in the study. Visit Trial Locations.

The I-SPY 2 Trial is sponsored by Quantum Leap Healthcare Collaborative, a 501(c)(3) charitable organization integrating high-impact clinical research with patient care.

This link leads to the machine-readable files that are made available in response to the federal Transparency in Coverage Rule and includes negotiated service rates and out-of-network allowed amounts between health plans and healthcare providers. The machine readable files are formatted to allow researchers, regulators, and application developers to more easily access and analyze data.